Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicenter Observational Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic Non-small Cell Lung Cancer: (J-TAIL)

NCT03645330 is registered in ClinicalTrials.gov with Chugai Pharmaceutical as lead sponsor.

NCT NCT03645330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03645330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicenter Observational Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic Non-small Cell Lung Cancer: (J-TAIL)
Lead sponsor
Chugai Pharmaceutical
Phase
Observational
Overall status
Completed
Start date
August 15, 2018
Completion date
July 8, 2021
Enrollment
1,026 (actual)
Sites
198

Conditions

As the registry lists them; a condition with its own page is linked.

non-small-cell lung cancer